Park Ha Biological Techno...

NASDAQ: PHH · Real-Time Price · USD
0.58
-0.04 (-5.69%)
At close: Aug 14, 2025, 3:59 PM
0.58
0.00%
Pre-market: Aug 15, 2025, 05:39 AM EDT

Park Ha Biological Technology Income Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Oct 31, 2024 Oct 31, 2023 Oct 31, 2022 Oct 31, 2021
Revenue
2.38M 2.46M 1.92M 931.04K
Cost of Revenue
195.34K 310.99K 509.16K 311.16K
Gross Profit
2.19M 2.15M 1.41M 619.87K
Operating Income
793.71K 1.18M 197.02K -501K
Interest Income
783.00 1.59K 263.00 167.00
Pretax Income
793.42K 1.18M 190.01K -485K
Net Income
478.56K 852.04K 191.3K -485K
Selling & General & Admin
1.18M 784.57K 1.15M 1.12M
Research & Development
36.71K 30.88K 60.67K n/a
Other Expenses
179.9K 152.11K 6.44K n/a
Operating Expenses
1.39M 967.56K 1.21M 1.12M
Interest Expense
n/a n/a 194.00 1.19K
Selling & Marketing Expenses
361.33K 299.62K 438.6K 369.03K
Cost & Expenses
1.59M 1.28M 1.72M 1.43M
Income Tax Expense
314.86K 329.53K -1.29K n/a
Shares Outstanding (Basic)
26.2M 26.2M 26.2M 26.2M
Shares Outstanding (Diluted)
26.2M 26.2M 26.2M 26.2M
EPS (Basic)
0.02 0.03 0.01 -0.02
EPS (Diluted)
0.02 0.03 0.01 -0.02
EBITDA
816.4K 1.2M 220.69K -445K
EBIT
793.71K 1.18M 190.2K -484K
Depreciation & Amortization
22.69K 20.06K 30.49K 39.01K